Corporate America weighs business impact of new weight-loss drugs
A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Boxes of Ozempic, a semaglutide injection drug used for treatin...